Circulating Th17, Th22, and Th1 cells are elevated in the guillain-barré syndrome and downregulated by IVIg treatments

Mediators of Inflammation

Volumn 2014, Issue , 2014, Pages

  Li, Shujuan ^a,b   Jin, Tao ^a   Zhang, Hong Liang ^a,c   Yu, Hong ^a,c   Meng, Fanhua ^a   Concha Quezada, Hernan ^c   Zhu, Jie ^a,c  

^a JILIN UNIVERSITY   (China)

^b NANJING MEDICAL UNIVERSITY   (China)

^c KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN; INTERLEUKIN 17; INTERLEUKIN 22; CYTOKINE; INTERLEUKIN DERIVATIVE; INTERLEUKIN-22;

ADOLESCENT; ADULT; ARTICLE; BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; DOWN REGULATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; GUILLAIN BARRE SYNDROME; HELPER CELL; HUMAN; IMMUNOTHERAPY; INFLAMMATORY CELL; LYMPHOCYTE COUNT; LYMPHOCYTE FUNCTION; MALE; MENINGITIS; MULTIPLE SCLEROSIS; RELAPSE; TH1 CELL; TH17 CELL; TH22 CELL; VIRUS ENCEPHALITIS; BLOOD; GENE EXPRESSION REGULATION; IMMUNOLOGY; MIDDLE AGED; MONONUCLEAR CELL; RECURRENT DISEASE; YOUNG ADULT;

ADOLESCENT; ADULT; CYTOKINES; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION REGULATION; GUILLAIN-BARRE SYNDROME; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; INTERLEUKIN-17; INTERLEUKINS; LEUKOCYTES, MONONUCLEAR; MALE; MIDDLE AGED; RECURRENCE; TH1 CELLS; TH17 CELLS; YOUNG ADULT;

EID: 84901800327     PISSN: 09629351     EISSN: 14661861     Source Type: Journal    
DOI: 10.1155/2014/740947     Document Type: Article

References (42)

1. Hadden R. D. M., Cornblath D. R., Hughes R. A. C., Zielasek J., Hartung H.-P., Toyka K. V., Swan A. V., Electrophysiological classification of Guillain-Barre syndrome: clinical associations and outcome. Annals of Neurology 1998 44 5 780 788 2-s2.0-0031768424 (Pubitemid 28516049)
2. Ho T. W., Mishu B., Li C. Y., Gao C. Y., Cornblath D. R., Griffin J. W., Asbury A. K., Blaser M. J., McKhann G. M., Guillain-Barre syndrome in northern China. Relationship to Campylobacter jejuni infection and anti-glycolipid antibodies. Brain 1995 118 3 597 605 2-s2.0-0029017652
3. Islam Z., Jacobs B. C., Van Belkum A., Mohammad Q. D., Islam M. B., Herbrink P., Diorditsa S., Luby S. P., Talukder K. A., Endtz H. P., Axonal variant of Guillain-Barré syndrome associated with Campylobacter infection in Bangladesh. Neurology 2010 74 7 581 587 2-s2.0-77149173477 10.1212/WNL.0b013e3181cff735
4. Yuki N., Hartung H. P., Guillain-Barré syndrome. The New England Journal of Medicine 2012 366 2294 2304
5. Borsellino G., Koul O., Placido R., Tramonti D., Luchetti S., Galgani S., Salvetti M., Gasperini C., Ristori G., Bonetti B., Bach S., Cipriani B., Battistini L., Evidence for a role of γ δ T cells in demyelinating diseases as determined by activation states and responses to lipid antigens. Journal of Neuroimmunology 2000 107 2 124 129 2-s2.0-0034709771 10.1016/S0165-5728(00)00220-4 (Pubitemid 30347417)
6. Tatsumoto M., Koga M., Gilbert M., Odaka M., Hirata K., Kuwabara S., Yuki N., Spectrum of neurological diseases associated with antibodies to minor gangliosides GM1b and GalNAc-GD1a. Journal of Neuroimmunology 2006 177 1-2 201 208 2-s2.0-33746721540 10.1016/j.jneuroim.2006.04.005 (Pubitemid 44164342)
7. Deng H., Yang X., Jin T., Wu J., Hu L.-S., Chang M., Sun X.-J., Adem A., Winblad B., Zhu J., The role of IL-12 and TNF- α in AIDP and AMAN. European Journal of Neurology 2008 15 10 1100 1105 2-s2.0-51349128257 10.1111/j.1468-1331.2008.02261.x
8. Zhu J., Mix E., Link H., Cytokine production and the pathogenesis of experimental autoimmune neuritis and Gulllain-Barre syndrome. Journal of Neuroimmunology 1998 84 1 40 52 2-s2.0-0032054104 10.1016/S0165-5728(97)00238-5 (Pubitemid 28210448)
9. Zhang H. L., Azimullah S., Zheng X. Y., Wang X. K., Amir N., Mensah-Brown E. P., IFN-gamma deficiency exacerbates experimental autoimmune neuritis in mice despite a mitigated systemic Th1 immune response. Journal of Neuroimmunology 2012 246 18 26
10. Hohnoki K., Inoue A., Koh C.-S., Elevated serum levels of IFN- γ IL-4 and TNF- α /unelevated serum levels of IL-10 in patients with demyelinating diseases during the acute stage. Journal of Neuroimmunology 1998 87 1-2 27 32 2-s2.0-0032126914 10.1016/S0165-5728(98)00053-8 (Pubitemid 28319841)
11. Putzu G. A., Figarella-Branger D., Bouvier-Labit C., Liprandi A., Bianco N., Pellissier J. F., Immunohistochemical localization of cytokines, C5b-9 and ICAM-1 in peripheral nerve of Guillain-Barre Syndrome. Journal of the Neurological Sciences 2000 174 1 16 21 2-s2.0-0033955339 10.1016/S0022-510X(99) 00328-7 (Pubitemid 30110543)
12. Infante-Duarte C., Horton H. F., Byrne M. C., Kamradt T., Microbial lipopeptides induce the production of IL-17 in Th cells. Journal of Immunology 2000 165 11 6107 6115 2-s2.0-0034541221
13. Aggarwal S., Ghilardi N., Xie M.-H., De Sauvage F. J., Gurney A. L., Interleukin-23 promotes a distinct CD4 T cell activation state characterized by the production of interleukin-17. Journal of Biological Chemistry 2003 278 3 1910 1914 2-s2.0-0037449737 10.1074/jbc.M207577200 (Pubitemid 36801431)
14. Langrish C. L., Chen Y., Blumenschein W. M., Mattson J., Basham B., Sedgwick J. D., McClanahan T., Kastelein R. A., Cua D. J., IL-23 drives a pathogenic T cell population that induces autoimmune inflammation. Journal of Experimental Medicine 2005 201 2 233 240 2-s2.0-13244283212 10.1084/jem.20041257 (Pubitemid 40189432)
15. Yang X. O., Pappu B. P., Nurieva R., Akimzhanov A., Kang H. S., Chung Y., Ma L., Shah B., Panopoulos A. D., Schluns K. S., Watowich S. S., Tian Q., Jetten A. M., Dong C., T helper 17 lineage differentiation is programmed by orphan nuclear receptors ROR α and ROR γ Immunity 2008 28 1 29 39 2-s2.0-37849048599 10.1016/j.immuni.2007.11.016
16. Miossec P., Korn T., Kuchroo V. K., Interleukin-17 and type 17 helper T cells. The New England Journal of Medicine 2009 361 9 888 898 2-s2.0-69349093225 10.1056/NEJMra0707449
17. Trifari S., Kaplan C. D., Tran E. H., Crellin N. K., Spits H., Identification of a human helper T cell population that has abundant production of interleukin 22 and is distinct from TH-17, TH1 and TH2 cells. Nature Immunology 2009 10 8 864 871 2-s2.0-67651171182 10.1038/ni.1770
18. Olsen T., Rismo R., Cui G., Goll R., Christiansen I., Florholmen J., TH1 and TH17 interactions in untreated inflamed mucosa of inflammatory bowel disease, and their potential to mediate the inflammation. Cytokine 2011 56 3 633 640 2-s2.0-80655122800 10.1016/j.cyto.2011.08.036
19. Schmechel S., Konrad A., Diegelmann J., Glas J., Wetzke M., Paschos E., Lohse P., Göke B., Brand S., Linking genetic susceptibility to Crohn's disease with Th17 cell function: IL-22 serum levels are increased in Crohn's disease and correlate with disease activity and IL23R genotype status. Inflammatory Bowel Diseases 2008 14 2 204 212 2-s2.0-39649121919 10.1002/ibd.20315 (Pubitemid 351288041)
20. Wolk K., Witte E., Hoffmann U., Doecke W.-D., Endesfelder S., Asadullah K., Sterry W., Volk H.-D., Wittig B. M., Sabat R., IL-22 induces lipopolysaccharide-binding protein in hepatocytes: a potential systemic role of IL-22 in Crohn's disease. Journal of Immunology 2007 178 9 5973 5981 2-s2.0-34247556456 (Pubitemid 46674395)
21. Kagami S., Rizzo H. L., Lee J. J., Koguchi Y., Blauvelt A., Circulating Th17, Th22, and Th1 cells are increased in psoriasis. Journal of Investigative Dermatology 2010 130 5 1373 1383 2-s2.0-77951091571 10.1038/jid.2009.399
22. Brucklacher-Waldert V., Stuerner K., Kolster M., Wolthausen J., Tolosa E., Phenotypical and functional characterization of T helper 17 cells in multiple sclerosis. Brain 2009 132 12 3329 3341 2-s2.0-72649089874 10.1093/brain/awp289
23. Li X.-L., Dou Y.-C., Liu Y., Shi C.-W., Cao L.-L., Zhang X.-Q., Zhu J., Duan R.-S., Atorvastatin ameliorates experimental autoimmune neuritis by decreased Th1/Th17 cytokines and up-regulated T regulatory cells. Cellular Immunology 2011 271 2 455 461 2-s2.0-80054016795 10.1016/j.cellimm.2011.08.015
24. Asbury A. K., Cornblath D. R., Assessment of current diagnostic criteria for Guillain-Barre syndrome. Annals of Neurology 1990 27 S21 S24 2-s2.0-0025375133 10.1002/ana.410270707 (Pubitemid 20178648)
25. Hughes R. A. C., Newsom-Davis J. M., Perkin G. D., Pierce J. M., Controlled trial of prednisolone in acute polyneuropathy. The Lancet 1978 2 8093 750 753 2-s2.0-0018119702 (Pubitemid 9034500)
26. McDonald W. I., Compston A., Edan G., Goodkin D., Hartung H.-P., Lublin F. D., McFarland H. F., Paty D. W., Polman C. H., Reingold S. C., Sandberg-Wollheim M., Sibley W., Thompson A., Van Den Noort S., Weinshenker B. Y., Wolinsky J. S., Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the Diagnosis of Multiple Sclerosis. Annals of Neurology 2001 50 1 121 127 2-s2.0-0034955141 10.1002/ana.1032 (Pubitemid 32591472)
27. Ouyang W., Kolls J. K., Zheng Y., The biological functions of T helper 17 cell effector cytokines in inflammation. Immunity 2008 28 4 454 467 2-s2.0-41549135632 10.1016/j.immuni.2008.03.004 (Pubitemid 351471762)
28. Torchinsky M. B., Blander J. M., T helper 17 cells: discovery, function, and physiological trigger. Cellular and Molecular Life Sciences 2010 67 9 1407 1421 2-s2.0-77952315857 10.1007/s00018-009-0248-3
29. Park H., Li Z., Yang X. O., Chang S. H., Nurieva R., Wang Y.-H., Wang Y., Hood L., Zhu Z., Tian Q., Dong C., A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17. Nature Immunology 2005 6 11 1133 1141 2-s2.0-27544465354 10.1038/ni1261 (Pubitemid 41541791)
30. + effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nature Immunology 2005 6 11 1123 1132 2-s2.0-27544490377 10.1038/ni1254 (Pubitemid 41541790)
31. Volpe E., Touzot M., Servant N., Marloie-Provost M.-A., Hupé P., Barillot E., Soumelis V., Multiparametric analysis of cytokine-driven human Th17 differentiation reveals a differential regulation of IL-17 and IL-22 production. Blood 2009 114 17 3610 3614 2-s2.0-70449479858 10.1182/blood-2009- 05-223768
32. Zhang L., Li J.-M., Liu X.-G., Ma D.-X., Hu N.-W., Li Y.-G., Li W., Hu Y., Yu S., Qu X., Yang M.-X., Feng A.-L., Wang G.-H., Elevated Th22 cells correlated with Th17 cells in patients with rheumatoid arthritis. Journal of Clinical Immunology 2011 31 4 606 614 2-s2.0-80555150814 10.1007/s10875-011- 9540-8
33. Maimone D., Annunziata P., Simone I. L., Livrea P., Guazzi G. C., Interleukin-6 levels in the cerebrospinal fluid and serum of patients with Guillain-Barre syndrome and chronic inflammatory demyelinating polyradiculoneuropathy. Journal of Neuroimmunology 1993 47 1 55 62 2-s2.0-0027302864 10.1016/0165-5728(93)90284-6 (Pubitemid 23274635)
34. Press R., Ozenci V., Kouwenhoven M., Link H., Non-TH1 cytokines are augmented systematically early in Guillain-Barré syndrome. Neurology 2002 58 3 476 478 2-s2.0-0037065844 (Pubitemid 34154879)
35. Crow A. R., Brinc D., Lazarus A. H., New insight into the mechanism of action of IVIg: the role of dendritic cells. Journal of Thrombosis and Haemostasis 2009 7 supplement 1 245 248 2-s2.0-67849121520 10.1111/j.1538-7836. 2009.03420.x
36. Hartung H.-P., Advances in the understanding of the mechanism of action of IVIg. Journal of Neurology 2008 255 3 3 6 2-s2.0-49249124978 10.1007/s00415-008-3002-0
37. Andersson U., Björk L., Skansén-Saphir U., Andersson J., Pooled human IgG modulates cytokine production in lymphocytes and monocytes. Immunological Reviews 1994 139 1 21 42 2-s2.0-0028168262 (Pubitemid 24232670)
38. Van Schaik I. N., Lundkvist I., Vermeulen M., Brand A., Polyvalent immunoglobulin for intravenous use interferes with cell proliferation in vitro. Journal of Clinical Immunology 1992 12 5 325 334 2-s2.0-0026646569
39. Hemmer B., Nessler S., Zhou D., Kieseier B., Hartung H.-P., Immunopathogenesis and immunotherapy of multiple sclerosis. Nature Clinical Practice Neurology 2006 2 4 201 211 2-s2.0-33645376448 10.1038/ncpneuro0154
40. Maddur M. S., Vani J., Hegde P., Lacroix-Desmazes S., Kaveri S. V., Bayry J., Inhibition of differentiation, amplification, and function of human TH17 cells by intravenous immunoglobulin. Journal of Allergy and Clinical Immunology 2011 127 3 823.e7 830.e7 2-s2.0-79952313700 10.1016/j.jaci.2010.12.1102
41. Maddur M. S., Kaveri S. V., Bayry J., Comparison of different IVIg preparations on IL-17 production by human Th17 cells. Autoimmunity Reviews 2011 10 12 809 810 2-s2.0-80053231181 10.1016/j.autrev.2011.02.007
42. Sugita S., Kawazoe Y., Imai A., Kawaguchi T., Horie S., Keino H., Role of IL-22- and TNF- α -producing Th22 cells in uveitis patients with Behcet's disease. Journal of Immunology 2013 190 5799 5808